©istockphoto/kwanchaichaiudom
New research funded by the National Institute on Drug Abuse (NIDA) revealed that the initial relapse rates among opioid-dependent adults in the criminal justice system was lower for participants receiving extended-release naltrexone than for those receiving treatment...
↧
